{"id":43849,"date":"2023-03-22T09:36:10","date_gmt":"2023-03-22T09:36:10","guid":{"rendered":"https:\/\/positivelysharing.org\/blog\/?p=43849"},"modified":"2023-03-22T09:36:10","modified_gmt":"2023-03-22T09:36:10","slug":"weight-gain-raised-bp-risk-seen-for-hiv-patients-switching-to-dolutegravir","status":"publish","type":"post","link":"https:\/\/positivelysharing.org\/blog\/2023\/03\/22\/weight-gain-raised-bp-risk-seen-for-hiv-patients-switching-to-dolutegravir\/","title":{"rendered":"Weight Gain, Raised BP Risk Seen for HIV Patients Switching to Dolutegravir"},"content":{"rendered":"<span class=\"span-reading-time rt-reading-time\" style=\"display: block;\"><span class=\"rt-label rt-prefix\">Reading Time: <\/span> <span class=\"rt-time\"> &lt; 1<\/span> <span class=\"rt-label rt-postfix\">minute<\/span><\/span><p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-24578\" src=\"https:\/\/positivelysharing.org\/blog\/wp-content\/uploads\/2020\/08\/arvs.jpg\" alt=\"\" width=\"250\" height=\"166\" \/><\/p>\n<p>For Black patients with HIV on antiretroviral therapy (ART), those who switch from efavirenz to dolutegravir gain more weight and have an increased risk for hypertension,\u00a0 <a href=\"https:\/\/consumer.healthday.com\/physician-s-briefing-hiv-2659501912.html\">Read More<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p><span class=\"span-reading-time rt-reading-time\" style=\"display: block;\"><span class=\"rt-label rt-prefix\">Reading Time: <\/span> <span class=\"rt-time\"> &lt; 1<\/span> <span class=\"rt-label rt-postfix\">minute<\/span><\/span>For Black patients with HIV on antiretroviral therapy (ART), those who switch from efavirenz to dolutegravir gain more weight and have an&#8230;<\/p>\n","protected":false},"author":1,"featured_media":25248,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[159],"tags":[],"class_list":{"0":"post-43849","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-hiv-2"},"jetpack_featured_media_url":"https:\/\/positivelysharing.org\/blog\/wp-content\/uploads\/2020\/10\/Dolutegravir.jpg","amp_enabled":true,"_links":{"self":[{"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/posts\/43849","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/comments?post=43849"}],"version-history":[{"count":1,"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/posts\/43849\/revisions"}],"predecessor-version":[{"id":43850,"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/posts\/43849\/revisions\/43850"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/media\/25248"}],"wp:attachment":[{"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/media?parent=43849"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/categories?post=43849"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/tags?post=43849"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}